These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 20881438
1. Acute effects of levosimendan on cerebral and systemic perfusion and oxygenation in newborns: an observational study. Bravo MC, López P, Cabañas F, Pérez-Rodríguez J, Pérez-Fernández E, Quero J, Pellicer A. Neonatology; 2011; 99(3):217-23. PubMed ID: 20881438 [Abstract] [Full Text] [Related]
7. Timing of levosimendan in cardiac surgery. Aksun M, Karahan N, Adanir T, Aran G, Yetkin U, Oztürk T, Sencan A, Ozgürbüz U, Gürbüz A. Anadolu Kardiyol Derg; 2009 Jun; 9(3):223-30. PubMed ID: 19520657 [Abstract] [Full Text] [Related]
8. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass. Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ. Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188 [Abstract] [Full Text] [Related]
9. Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases. Papoff P, Caresta E, Versacci P, Pinto R, Moretti C, Midulla F. Pediatr Emerg Care; 2012 Oct; 28(10):1062-5. PubMed ID: 23034494 [Abstract] [Full Text] [Related]
10. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. Momeni M, Rubay J, Matta A, Rennotte MT, Veyckemans F, Poncelet AJ, Clement de Clety S, Anslot C, Joomye R, Detaille T. J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):419-24. PubMed ID: 20829069 [Abstract] [Full Text] [Related]
11. Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial. Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE. Intensive Care Med; 2012 Jul; 38(7):1198-204. PubMed ID: 22527079 [Abstract] [Full Text] [Related]
12. Intracoronary infusion of levosimendan to treat postpericardiotomy heart failure. Caimmi PP, Grossini E, Molinari C, Vacca G, Teodori G. Ann Thorac Surg; 2006 Nov; 82(5):e33-4. PubMed ID: 17062205 [Abstract] [Full Text] [Related]
13. Levosimendan: a new dual-action drug in the treatment of acute heart failure. Mebazaa A, Erhardt L. Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347 [Abstract] [Full Text] [Related]
16. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Tasouli A, Papadopoulos K, Antoniou T, Kriaras I, Stavridis G, Degiannis D, Geroulanos S. Eur J Cardiothorac Surg; 2007 Oct; 32(4):629-33. PubMed ID: 17702589 [Abstract] [Full Text] [Related]
17. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock. Rokyta R, Pechman V. Neuro Endocrinol Lett; 2006 Oct; 27(1-2):121-7. PubMed ID: 16648778 [Abstract] [Full Text] [Related]
18. Phase 1 study of two inodilators in neonates undergoing cardiovascular surgery. Pellicer A, Riera J, Lopez-Ortego P, Bravo MC, Madero R, Perez-Rodriguez J, Labrandero C, Quero J, Buño A, Castro L, Lubomirov R, Cabañas F. Pediatr Res; 2013 Jan; 73(1):95-103. PubMed ID: 23138399 [Abstract] [Full Text] [Related]
19. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery. Bredin F, Franco-Cereceda A. Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771 [Abstract] [Full Text] [Related]